17-alpha-hydroxypregnenolone has been researched along with Turner Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balducci, R; Boscherini, B; Di Rito, A; Galasso, C; Larizza, D; Mangiantini, A; Municchi, G; Picone, S; Toscano, V | 1 |
| Mackay, AM; Neville, AM; Pettigrew, N; Symington, T | 1 |
2 other study(ies) available for 17-alpha-hydroxypregnenolone and Turner Syndrome
| Article | Year |
|---|---|
Effects of long-term growth hormone therapy on adrenal steroidogenesis in Turner syndrome.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Androstenedione; Child; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Human Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Time Factors; Turner Syndrome | 1998 |
Tumors of dysgenetic gonads (gonadoblastoma): ultrastructural and steroidogenic aspects.
Topics: 17-alpha-Hydroxypregnenolone; Androstenedione; Androstenes; Basement Membrane; Cell Nucleus; Cytoplasm; Dehydroepiandrosterone; Dysgerminoma; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Hydroxyprogesterones; In Vitro Techniques; Pregnenolone; Progesterone; Testosterone; Turner Syndrome | 1974 |